NCT02845180View on ClinicalTrials.gov

In-Vivo Assessment of Adipose Allograft Extracellular Matrix in Abdominoplasty Patients

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

June 15, 2018

Study Completion Date

June 15, 2018

Conditions
Obesity
Interventions
PROCEDURE

Adipose Allograft Extracellular Matrix (AAM) Injection

Injection followed by surgery

Trial Locations (1)

15261

University of Pittsburgh, Philadelphia

All Listed Sponsors
lead

Musculoskeletal Transplant Foundation

OTHER

NCT02845180 - In-Vivo Assessment of Adipose Allograft Extracellular Matrix in Abdominoplasty Patients | Biotech Hunter | Biotech Hunter